We have demonstrated multiple times that the TGase 2 inhibitor GK921 [6,23] or streptonigrin (this paper) induces a marked remission of RCC tumors in models based on RCC cell lines such as ACHN and CAKI-1. This evidence concerns the gene TGM2 and renal cell carcinoma.